NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy

NCT07227909 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
83
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

M.D. Anderson Cancer Center

Collaborators